Key facts
- Bleichroeder LP filed SCHEDULE 13G for NEUROONE MEDICAL TECHNOLOGIES ORD Common Shares (NMTC).
- Disclosed ownership: 8%.
- Date of event: 30 Jun 2025.
Bleichroeder LP - 30 Jun 2025 SCHEDULE 13G Report for NEUROONE MEDICAL TECHNOLOGIES ORD Common Shares (NMTC)
- Filing Manager
- Bleichroeder LP
- Reporting Manager
- Bleichroeder LP
- Symbol
- NMTC
- Shares outstanding
- 49,813,200 shares
- Disclosed Ownership
- 4,000,000 shares
- Ownership
- 8%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Aug 2025, 11:17:30 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Key filing fact
Bleichroeder LP disclosed 8% ownership in NEUROONE MEDICAL TECHNOLOGIES ORD Common Shares (NMTC) on 30 Jun 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 11:17.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bleichroeder LP | 8% | 4,000,000 | 4,000,000 | 0 | Andew Gundlach | President and CEO | |
| Bleichroeder Holdings LLC | 8% | 4,000,000 | 4,000,000 | 0 | Andew Gundlach | President and CEO | |
| Andew Gundlach | 8% | 4,000,000 | 4,000,000 | 0 | Andew Gundlach | President and CEO |
CIK / CUSIP context first